Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.45
0.12 (1.06%)
At close: Aug 18, 2025, 3:03 PM

Cartesian Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.99 -0.46 3.85 -12.09
PEG Ratio
0.06 0.00 -0.02 0.18
PS Ratio
11.92 3.91 1.23 3.65
PB Ratio
-68.21 -0.23 1.45 13.79
P/FCF Ratio
-14.16 -1.98 -4.15 -5.05
P/OCF Ratio
-19.6 -1.99 -4.31 -5.14
OCF/S Ratio
-0.61 -1.97 -0.29 -0.71
Debt / Equity Ratio
-2.06 -0.02 0.40 1.57
Quick Ratio
9.43 1.33 5.91 2.00
Current Ratio
9.43 1.33 5.91 2.00
Asset Turnover
0.09 0.09 0.67 0.53
Interest Coverage
n/a -30.5 4.80 -1.62
Return on Equity
11.38 0.50 0.38 -1.14
Return on Assets
-0.18 -0.72 0.21 -0.16
Return on Invested Capital
-0.11 -0.33 0.10 -0.13
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 0.94 0.98 1.00
Net Profit Margin
-1.99 -8.45 0.32 -0.3
Pretax Profit Margin
-1.98 -9.18 0.31 -0.11
Operating Profit Margin
-1.13 -3.32 0.13 -0.05
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.98 -9.04 0.36 -0.06